National Burden of Invasive Methicillin-ResistantStaphylococcus aureusInfections, United States, 2011
Authors:
Open Access
- 16 September 2013
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 173 (21) , 1970-1978
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) continues to be one of the most common antimicrobial-resistant pathogens causing invasive infections, both in health care settings and in the community.1-4 In the United States, MRSA is the predominant pathogen causing skin and soft tissue infections,5 and reports using administrative data documented increases in the number of estimated hospitalizations in which International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes indicating MRSA infection were present.6,7Keywords
This publication has 14 references indexed in Scilit:
- Community associated methicillin-resistant Staphylococcus aureus.Acta Clinica Belgica, 2012
- Increasing Burden of Methicillin-Resistant Staphylococcus aureus Hospitalizations at US Academic Medical Centers, 2003–2008Infection Control & Hospital Epidemiology, 2012
- Epidemiology of Staphylococcus aureus Blood and Skin and Soft Tissue Infections in the US Military Health System, 2005-2010JAMA, 2012
- Comparison of Staphylococcus aureus From Skin and Soft-Tissue Infections in US Emergency Department Patients, 2004 and 2008Clinical Infectious Diseases, 2011
- Epidemiology, Surveillance, and Prevention of Bloodstream Infections in Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2010
- Health Care–Associated Invasive MRSA Infections, 2005-2008JAMA, 2010
- Methicillin-Resistant Staphylococcus aureus Central Line–Associated Bloodstream Infections in US Intensive Care Units, 1997-2007JAMA, 2009
- Hospitalizations and Deaths Caused by Methicillin-ResistantStaphylococcus aureus, United States, 1999–2005Emerging Infectious Diseases, 2007
- Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United StatesJAMA, 2007
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987